Ra-Capital-Management-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "ASND",
  "EWTX",
  "INSM",
  "NAMS",
  "CBLL",
  "ACHC",
  "RXST",
  "BCAX",
  "BCYC",
  "ATXS",
  "RCUS",
  "GPCR",
  "IMTX",
  "SCLX",
  "TVTX",
  "TSHA",
  "TRML",
  "TYRA",
  "LENZ",
  "ACET",
  "NRIX",
  "ACRV",
  "LRMR",
  "MLYS",
  "ABOS",
  "ALEC",
  "AVTX",
  "JANX",
  "ARTV",
  "BIOA",
  null,
  null,
  "GERN",
  "SRRK",
  "FULC",
  "APGE",
  "LXEO",
  null,
  "MNPR",
  "NKTX",
  "SEPN",
  "SRZN",
  "STRO",
  "GHRS",
  "TARA",
  "ACRS",
  "TXG",
  "IDYA",
  "ZURA",
  "SPRY",
  null,
  null,
  "SERA",
  "PEPG",
  "RNA",
  "MBX",
  null,
  "SLDB",
  "FDMT",
  "RYTM",
  "ACLX",
  "ETNB",
  "DYN",
  "BOLD",
  null,
  "GKOS",
  "HUMA",
  "WVE",
  null,
  "CDTX",
  "ELDN",
  "ELVN",
  "EYPT",
  "ITOS",
  "KURA",
  "URGN",
  "VOR",
  "HOWL",
  "ZLAB",
  "XNCR",
  "PCVX",
  "DAWN",
  "CTMX",
  "DNTH",
  "IRON"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 85
Total Value: 5952606666
Accession Number: 0001104659-25-049549
Form Type: 13F-HR
CIK: ra-capital-management-lp
Manager Name: Ra-Capital-Management-Lp

Data Enrichment

91% identified

77 identified8 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

85 positions • $6.0B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 3 of 5

Sort by:

Nkarta, Inc.

NKTX|65487U108

Shares:10.8M

Value:$19.9M

% of Portfolio:0.3% ($19.9M/$6.0B)

GLAUKOS Corp

GKOS|377322102

Shares:190.3K

Value:$18.7M

% of Portfolio:0.3% ($18.7M/$6.0B)

Monopar Therapeutics

MNPR|61023L207

Shares:511.2K

Value:$18.6M

% of Portfolio:0.3% ($18.6M/$6.0B)

59267L107

Shares:675.5K

Value:$18.4M

% of Portfolio:0.3% ($18.4M/$6.0B)

EyePoint Pharmaceuticals, Inc.

EYPT|30233G209

Shares:3.2M

Value:$17.2M

% of Portfolio:0.3% ($17.2M/$6.0B)

10x Genomics, Inc.

TXG|88025U109

Shares:1.9M

Value:$17.0M

% of Portfolio:0.3% ($17.0M/$6.0B)

Acrivon Therapeutics, Inc.

ACRV|004890109

Shares:8.3M

Value:$16.9M

% of Portfolio:0.3% ($16.9M/$6.0B)

Enliven Therapeutics, Inc.

ELVN|29337E102

Shares:849.0K

Value:$16.7M

% of Portfolio:0.3% ($16.7M/$6.0B)

Acumen Pharmaceuticals, Inc.

ABOS|00509G209

Shares:14.9M

Value:$16.4M

% of Portfolio:0.3% ($16.4M/$6.0B)

Solid Biosciences Inc.

SLDB|83422E204

Shares:4.3M

Value:$16.0M

% of Portfolio:0.3% ($16.0M/$6.0B)

Ceribell, Inc.

CBLL|15678C102

Shares:824.6K

Value:$15.8M

% of Portfolio:0.3% ($15.8M/$6.0B)

Nurix Therapeutics, Inc.

NRIX|67080M103

Shares:1.3M

Value:$15.8M

% of Portfolio:0.3% ($15.8M/$6.0B)

INSMED Inc

INSM|457669307

Shares:200.0K

Value:$15.3M

% of Portfolio:0.3% ($15.3M/$6.0B)

Taysha Gene Therapies, Inc.

TSHA|877619106

Shares:10.9M

Value:$15.1M

% of Portfolio:0.3% ($15.1M/$6.0B)

PepGen Inc.

PEPG|713317105

Shares:10.7M

Value:$15.0M

% of Portfolio:0.3% ($15.0M/$6.0B)

4D Molecular Therapeutics, Inc.

FDMT|35104E100

Shares:4.6M

Value:$14.7M

% of Portfolio:0.2% ($14.7M/$6.0B)

Protara Therapeutics, Inc.

TARA|74365U107

Shares:3.4M

Value:$14.5M

% of Portfolio:0.2% ($14.5M/$6.0B)

Larimar Therapeutics, Inc.

LRMR|517125100

Shares:6.0M

Value:$13.0M

% of Portfolio:0.2% ($13.0M/$6.0B)

Eledon Pharmaceuticals, Inc.

ELDN|28617K101

Shares:3.6M

Value:$12.1M

% of Portfolio:0.2% ($12.1M/$6.0B)

Alector, Inc.

ALEC|014442107

Shares:9.7M

Value:$11.9M

% of Portfolio:0.2% ($11.9M/$6.0B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Nkarta, Inc.(NKTXcusip65487U108)	10.8M	QoQ 0.00% (-0) YoY NEW(+10.8M)	All Managers (Combined)	$19.9M	0.3% ($19.9M/$6.0B)	QoQ -26.10% (-$7.0M) YoY NEW(+$19.9M)
GLAUKOS Corp(GKOScusip377322102)	190.3K	QoQ NEW(+190.3K) YoY NEW(+190.3K)	All Managers (Combined)	$18.7M	0.3% ($18.7M/$6.0B)	QoQ NEW(+$18.7M) YoY NEW(+$18.7M)
Monopar Therapeutics(MNPRcusip61023L207)	511.2K	QoQ 0.00% (+0) YoY NEW(+511.2K)	All Managers (Combined)	$18.6M	0.3% ($18.6M/$6.0B)	QoQ +65.50% (+$7.4M) YoY NEW(+$18.6M)
(cusip59267L107)✕	675.5K	QoQ NEW(+675.5K) YoY NEW(+675.5K)	All Managers (Combined)	$18.4M	0.3% ($18.4M/$6.0B)	QoQ NEW(+$18.4M) YoY NEW(+$18.4M)
EyePoint Pharmaceuticals, Inc.(EYPTcusip30233G209)	3.2M	QoQ 0.00% (-0) YoY NEW(+3.2M)	All Managers (Combined)	$17.2M	0.3% ($17.2M/$6.0B)	QoQ -27.24% (-$6.5M) YoY NEW(+$17.2M)
10x Genomics, Inc.(TXGcusip88025U109)	1.9M	QoQ -40.71% (-1.3M) YoY NEW(+1.9M)	All Managers (Combined)	$17.0M	0.3% ($17.0M/$6.0B)	QoQ -63.95% (-$30.1M) YoY NEW(+$17.0M)
Acrivon Therapeutics, Inc.(ACRVcusip004890109)	8.3M	QoQ 0.00% (-0) YoY NEW(+8.3M)	All Managers (Combined)	$16.9M	0.3% ($16.9M/$6.0B)	QoQ -66.27% (-$33.3M) YoY NEW(+$16.9M)
Enliven Therapeutics, Inc.(ELVNcusip29337E102)	849.0K	QoQ 0.00% (-0) YoY NEW(+849.0K)	All Managers (Combined)	$16.7M	0.3% ($16.7M/$6.0B)	QoQ -12.53% (-$2.4M) YoY NEW(+$16.7M)
Acumen Pharmaceuticals, Inc.(ABOScusip00509G209)	14.9M	QoQ 0.00% (-0) YoY NEW(+14.9M)	All Managers (Combined)	$16.4M	0.3% ($16.4M/$6.0B)	QoQ -36.04% (-$9.3M) YoY NEW(+$16.4M)
Solid Biosciences Inc.(SLDBcusip83422E204)	4.3M	QoQ 0.00% (-0) YoY NEW(+4.3M)	All Managers (Combined)	$16.0M	0.3% ($16.0M/$6.0B)	QoQ -7.50% (-$1.3M) YoY NEW(+$16.0M)
Ceribell, Inc.(CBLLcusip15678C102)	824.6K	QoQ 0.00% (-0) YoY NEW(+824.6K)	All Managers (Combined)	$15.8M	0.3% ($15.8M/$6.0B)	QoQ -25.77% (-$5.5M) YoY NEW(+$15.8M)
Nurix Therapeutics, Inc.(NRIXcusip67080M103)	1.3M	QoQ 0.00% (-0) YoY NEW(+1.3M)	All Managers (Combined)	$15.8M	0.3% ($15.8M/$6.0B)	QoQ -36.94% (-$9.3M) YoY NEW(+$15.8M)
INSMED Inc(INSMcusip457669307)	200.0K	QoQ 0.00% (+0) YoY NEW(+200.0K)	All Managers (Combined)	$15.3M	0.3% ($15.3M/$6.0B)	QoQ +10.50% (+$1.4M) YoY NEW(+$15.3M)
Taysha Gene Therapies, Inc.(TSHAcusip877619106)	10.9M	QoQ 0.00% (-0) YoY NEW(+10.9M)	All Managers (Combined)	$15.1M	0.3% ($15.1M/$6.0B)	QoQ -19.65% (-$3.7M) YoY NEW(+$15.1M)
PepGen Inc.(PEPGcusip713317105)	10.7M	QoQ 0.00% (-0) YoY NEW(+10.7M)	All Managers (Combined)	$15.0M	0.3% ($15.0M/$6.0B)	QoQ -62.92% (-$25.5M) YoY NEW(+$15.0M)
4D Molecular Therapeutics, Inc.(FDMTcusip35104E100)	4.6M	QoQ 0.00% (-0) YoY NEW(+4.6M)	All Managers (Combined)	$14.7M	0.2% ($14.7M/$6.0B)	QoQ -42.01% (-$10.7M) YoY NEW(+$14.7M)
Protara Therapeutics, Inc.(TARAcusip74365U107)	3.4M	QoQ 0.00% (-0) YoY NEW(+3.4M)	All Managers (Combined)	$14.5M	0.2% ($14.5M/$6.0B)	QoQ -19.31% (-$3.5M) YoY NEW(+$14.5M)
Larimar Therapeutics, Inc.(LRMRcusip517125100)	6.0M	QoQ 0.00% (-0) YoY NEW(+6.0M)	All Managers (Combined)	$13.0M	0.2% ($13.0M/$6.0B)	QoQ -44.44% (-$10.4M) YoY NEW(+$13.0M)
Eledon Pharmaceuticals, Inc.(ELDNcusip28617K101)	3.6M	QoQ 0.00% (-0) YoY NEW(+3.6M)	All Managers (Combined)	$12.1M	0.2% ($12.1M/$6.0B)	QoQ -17.71% (-$2.6M) YoY NEW(+$12.1M)
Alector, Inc.(ALECcusip014442107)	9.7M	QoQ 0.00% (-0) YoY NEW(+9.7M)	All Managers (Combined)	$11.9M	0.2% ($11.9M/$6.0B)	QoQ -34.92% (-$6.4M) YoY NEW(+$11.9M)